Position in GERN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$38,492
-$4,825 QoQ
Shares Held
30,072
+3.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#164
of 258 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$5,890
PutShares
3,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $701,516,965 across 82 Biotechnology names. GERN ranks #79 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
427,448 | $212,326,240 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
942,432 | $73,764,150 | |
| 3 | ARGX |
Argenx SE
|
77,213 | $71,635,902 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
103,247 | $64,378,631 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
242,063 | $58,329,919 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
515,981 | $28,347,995 | |
| 7 | MRNA |
Moderna, Inc.
|
389,789 | $27,296,921 | |
| 8 | CYTK |
Cytokinetics Inc
|
285,688 | $24,337,759 |
All Filings in GERN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,492 | 30,072 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $43,317 | 29,072 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $38,375 | 29,072 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $39,828 | 29,072 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $47,951 | 34,008 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $52,407 | 32,961 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $117,340 | 33,147 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $108,369 | 23,870 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $99,083 | 23,369 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $77,572 | 23,507 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $144,464 | 68,467 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $143,702 | 67,785 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $110,968 | 34,570 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $42,347 | 19,515 | Shares | Defined | 2024-06-13 | |
| 2022-06-30 | $5,890 | 3,800 | Put | Defined | 2022-08-11 | |
| 2022-06-30 | $11,762 | 7,589 | Shares | Defined | 2022-08-11 | |
| 2021-03-31 | $15,331 | 9,704 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $72,418 | 45,546 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $24,941 | 14,334 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $34,513 | 15,832 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,190 | 1,000 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||